Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2025 Earnings Call Transcript July 30, 2025
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $0.2429 EPS, expectations were $0.63.
Operator: Hello, and welcome to the Teva Pharmaceutical Industries Limited Q2 2025 Earnings Conference Call. My name is Alex. I’ll be coordinating the call for today. [Operator Instructions] I’ll now hand it over to Chris Stevo, SVP, Investor Relations. Please go...
